PET of αvbeta3-integrin and αvbeta5-integrin expression with 18F-fluciclatide for assessment of response to targeted therapy: ready for prime time? [electronic resource]
Producer: 20110412Description: 335-7 p. digitalISSN:- 1535-5667
- Angiogenesis Inhibitors -- therapeutic use
- Animals
- Cell Line, Tumor
- Glioblastoma -- diagnostic imaging
- Humans
- Indoles -- therapeutic use
- Integrin alphaVbeta3 -- metabolism
- Male
- Mice
- Mice, Nude
- Peptides -- pharmacokinetics
- Polyethylene Glycols -- pharmacokinetics
- Pyrroles -- therapeutic use
- Radionuclide Imaging
- Radiopharmaceuticals -- pharmacokinetics
- Receptors, Vitronectin -- metabolism
- Reproducibility of Results
- Sensitivity and Specificity
- Sunitinib
No physical items for this record
Publication Type: Journal Article; Comment
There are no comments on this title.
Log in to your account to post a comment.